Literature DB >> 15386606

Acute changes of cerebral venous blood flow in growth-restricted human fetuses in response to uterine contractions.

H Li1, S Gudmundsson, P Olofsson.   

Abstract

OBJECTIVE: The fetal cerebral venous circulation during acute hypoxic stress provoked by uterine contractions has not been studied previously. The aim of this study was to explore the cerebral venous circulation during an oxytocin challenge test (OCT) in intrauterine growth-restricted (IUGR) fetuses.
METHODS: Doppler recordings of blood flow in the vein of Galen (GV), straight sinus (SS) and transverse sinus (TS) before and during uterine contractions and relaxation were obtained at the same time as electronic fetal heart rate (FHR) monitoring in 44 term IUGR fetuses. The OCT was classified as negative (normal FHR) or positive (late FHR decelerations). Non-parametric statistics were used to test differences between OCT groups.
RESULTS: In OCT-negative cases (n = 39), de novo pulsations occurred in the GV, and SS flow velocities increased during contractions compared with basal measurements. There were no significant differences in TS flow. Flow recordings were less often obtained from OCT-positive cases (n = 5), making comparisons with OCT-negative cases uncertain.
CONCLUSIONS: In uncompromised IUGR fetuses an acute cerebral venous hyperperfusion develops in response to uterine contractions. Pulsations in the GV are detected but are unlikely to be an ominous sign in this situation. The more centrally located TS was less discriminating for acute cerebral venous blood flow changes.

Entities:  

Mesh:

Year:  2004        PMID: 15386606     DOI: 10.1002/uog.1709

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  1 in total

1.  Foetal heart rate power spectrum response to uterine contraction.

Authors:  M Romano; P Bifulco; M Cesarelli; M Sansone; M Bracale
Journal:  Med Biol Eng Comput       Date:  2006-02-21       Impact factor: 2.602

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.